Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,596 across all filing types
Latest filing 2018-11-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
关于控股股东股份质押延期购回的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the extension of the repurchase period for pledged shares by a controlling shareholder. It details the number of shares pledged, the original and extended pledge expiration dates, and confirms no risk to control or company financials. It is a regulatory disclosure about share pledge status and does not contain financial statements, earnings data, or management discussion. It is not a report, earnings release, or management information. It fits best as a Regulatory Filing (RNS) because it is a compliance disclosure about share pledge extension and related shareholder information.
2018-11-26 Chinese
独立董事候选人声明(卢北京)
Board/Management Information Classification · 95% confidence The document is a detailed declaration by an independent director candidate of a company, confirming compliance with various legal and regulatory requirements for serving as an independent director. It includes statements about qualifications, independence, and adherence to relevant laws and regulations. There is no financial data, no discussion of company financial performance, no voting results, no management changes, no earnings information, and no mention of report publication or regulatory filings. The content is focused on governance and compliance related to board membership qualifications. Therefore, the document fits best under Board/Management Information (MANG), as it relates to the announcement and declaration of a board member candidate's qualifications and independence.
2018-11-08 Chinese
独立董事关于相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion regarding the nomination and election of board members for the company's fourth board. It references compliance with company law and internal governance rules, and it is signed by independent directors. The content focuses on board/management changes and nominations rather than financial results or other report types. The document length is short and it is not a report or announcement of a report publication. Therefore, it fits best under Board/Management Information (MANG).
2018-11-08 Chinese
承诺书
Regulatory Filings Classification · 95% confidence The document is a short commitment letter (承诺书) from an individual named Cao Yanming regarding the independent director qualification certificate. It is only 200 characters long and does not contain any financial data, regulatory filings, or report content. It is a personal declaration related to board membership qualifications, not a report or announcement of financial results or corporate actions. This fits best under Regulatory Filings (RNS) as it is a compliance-related statement without substantive financial or corporate report content.
2018-11-08 Chinese
关于监事会换届选举的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election and composition of the company's supervisory board (监事会换届选举). It details the candidates for the new supervisory board, their qualifications, and the process for election. There is no financial data, no mention of financial results, no audit information, no voting results, and no reference to a report being published or attached. The content focuses on management/board changes specifically related to the supervisory board members. Therefore, this fits best under Board/Management Information (MANG). The document length is short (1894 characters), and it is clearly an announcement of board member changes rather than a full report or other filing type.
2018-11-08 Chinese
独立董事提名人声明(二)
Board/Management Information Classification · 95% confidence The document is a public statement by a nominator regarding the nomination of an independent director candidate for the company's board. It details the qualifications, compliance with regulatory requirements, and independence of the nominee. There is no financial data, no report of financial performance, no voting results, no legal proceedings, no capital changes, and no earnings information. The content is focused on board/management information, specifically the nomination of a board member. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is sufficient and contains detailed statements about the nominee's qualifications and compliance, confirming it is not a brief announcement or a regulatory filing but a substantive management-related disclosure.
2018-11-08 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.